International Clinical Trial: A multicenter, single-arm, open-label, confirmatory clinical study to evaluate the efficacy and safety of isosulfan blue injection for sentinel lymph node tracing in patients with early-stage breast cancer

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122184) titled 'A multicenter, single-arm, open-label, confirmatory clinical study to evaluate the efficacy and safety of isosulfan blue injection for sentinel lymph node tracing in patients with early-stage breast cancer' on April 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Peking University People's Hospital

Condition: Early-stage breast cancer sentinel lymph node tracing

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-10

Target Sample Size: treatment group:146;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showpro...